成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart Sign in  
Chemical Structure| 16382-15-3 Chemical Structure| 16382-15-3

Structure of 16382-15-3

Chemical Structure| 16382-15-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

{[proInfo.proName]}

CAS No.: 16382-15-3

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 16382-15-3 ]

CAS No. :16382-15-3
Formula : C12H13NO2
M.W : 203.24
SMILES Code : O=C(C(N1)=CC2=C1C=CC(C)=C2)OCC
MDL No. :MFCD00022703
InChI Key :KMVFKXFOPNKHEM-UHFFFAOYSA-N
Pubchem ID :232919

Safety of [ 16382-15-3 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H317
Precautionary Statements:P280

Computational Chemistry of [ 16382-15-3 ] Show Less

Physicochemical Properties

Num. heavy atoms 15
Num. arom. heavy atoms 9
Fraction Csp3 0.25
Num. rotatable bonds 3
Num. H-bond acceptors 2.0
Num. H-bond donors 1.0
Molar Refractivity 59.35
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

42.09 ?2

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

2.41
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

2.97
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

2.65
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

1.95
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

3.19
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

2.63

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-3.22
Solubility 0.123 mg/ml ; 0.000606 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-3.52
Solubility 0.0618 mg/ml ; 0.000304 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-4.16
Solubility 0.0142 mg/ml ; 0.0000697 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Moderately soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

Yes
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-5.43 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

0.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.88

Application In Synthesis of [ 16382-15-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 16382-15-3 ]

[ 16382-15-3 ] Synthesis Path-Downstream   1~32

  • 1
  • [ 64-17-5 ]
  • [ 89314-29-4 ]
  • [ 16382-15-3 ]
  • 3
  • [ 89-87-2 ]
  • [ 95-92-1 ]
  • [ 16382-15-3 ]
  • 5
  • [ 16382-15-3 ]
  • [ 97-00-7 ]
  • 1-(2,4-Dinitro-phenyl)-5-methyl-1H-indole-2-carboxylic acid ethyl ester [ No CAS ]
  • 6
  • [ 16382-15-3 ]
  • [ 89-61-2 ]
  • 1-(4-Chloro-2-nitro-phenyl)-5-methyl-1H-indole-2-carboxylic acid ethyl ester [ No CAS ]
  • 7
  • [ 16382-15-3 ]
  • [ 93704-67-7 ]
YieldReaction ConditionsOperation in experiment
98% With N-Bromosuccinimide; In tetrahydrofuran; at 20℃; for 3.5h; To a solution of S-methyl-lH-indole^-carboxylic acid ethyl ester, 3A (10.17 g, 50.03 mmol) in THF (100 mL) in a room temperature water bath was slowly added NBS (8.91 g, 50.06 mmol). The resulting solution was allowed to stir at room temperature for 3.5 h before water (800 mL) was added. The resulting mixture was allowed to stir at room temperature for 20 min and then filtered. The solid was washed with water (2 x 100 mL), dried in vacuo to provide the crude product 3B as a tan powder (13.8 g, 98percent yield). 1H NMR (500 MHz, CDC13): delta 8.91 (s, IH), 7.44 (q, J= 0.95 Hz 0.63 Hz, IH), 7.28 (d, J= 8.51 Hz, IH), 7.21 7.19 (dd, J= 1.58 Hz 8.51 Hz, IH), 4.46 (q, J= 6.94 Hz 7.25 Hz, 2H), 2.47 (s, 3H), 1.45 (t, J= 7.25 Hz, 3H).
  • 9
  • [ 16382-15-3 ]
  • [ 122-04-3 ]
  • 5-Methyl-4-(4-nitro-benzoyl)-1H-indole-2-carboxylic acid ethyl ester [ No CAS ]
  • 5-Methyl-7-(4-nitro-benzoyl)-1H-indole-2-carboxylic acid ethyl ester [ No CAS ]
  • 11
  • [ 235759-00-9 ]
  • [ 16382-15-3 ]
  • ethyl 7-methanesulfonyloxy-5-methylindole-2-carboxylate [ No CAS ]
YieldReaction ConditionsOperation in experiment
1% Ethyl 5-methylindole-2-carboxylate in 1percent yield (2 steps), mp 157-158°; NMR delta(CD3SOCD3) 1.3 (t, 3H), 2.35 (s, 3H), 4.3 (q, 2H), 7.05 (m, 2H), 7.35 (m, 2H), 11.7 (bs, 1H); M/z (+) 203 (M+).
B. 5-Methyl-1H-indole-2-carboxylic acid, ethyl ester The title A compound (2.095 g, 9.51 mmol, 1.0 eq) was dissolved in absolute ethanol (9.8 ml, 1M) and hydrochloric acid gas was bubbled through the reaction until it showed no starting material (45 minutes). The reaction solution was then concentrated, dissolved in ethyl acetate, and washed once with aqueous saturated sodium hydrogen carbonate. The organic phase was then dried over sodium sulfate, filtered through magnesium sulfate and concentrated. The residue was chromatographed on silica gel (60 g) eluding with toluene followed by chloroform:hexane (1:4) followed by ether:hexane (2:3) to give the title B compound (1.5187 g).
b Ethyl 5-methylindole-2-carboxylate 130 g of P2 O5 are added to 111 ml of orthophosphoric acid. After cooling, 37 g of the compound from a) are added, and the mixture is heated to 80° C. After the reaction starts, the temperature rises to 130° C. The mixture is cooled and then poured into ice-water and extracted with ethyl acetate. The organic phase is washed with NaHCO3 (1N), H2 O and saturated NaCl solution, dried with Na2 SO4 and concentrated. The product is recrystallized from n-hexane/EtOAc. 11.7 g of product of melting point 158° C. are obtained.
  • 15
  • [ 16382-15-3 ]
  • 3-Amino-7-methyl-5H-indolo[1,2-a]quinoxalin-6-one [ No CAS ]
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 16382-15-3 ]

Esters

Chemical Structure| 3770-50-1

A362351 [3770-50-1]

Ethyl indole-2-carboxylate

Similarity: 1.00

Chemical Structure| 16732-80-2

A126742 [16732-80-2]

Ethyl 4-methyl-1H-indole-2-carboxylate

Similarity: 0.97

Chemical Structure| 26304-51-8

A463569 [26304-51-8]

Ethyl 3-methyl-1H-indole-2-carboxylate

Similarity: 0.97

Chemical Structure| 1202-04-6

A187053 [1202-04-6]

Methyl 1H-indole-2-carboxylate

Similarity: 0.97

Chemical Structure| 107516-75-6

A261523 [107516-75-6]

Diethyl 1H-indole-2,6-dicarboxylate

Similarity: 0.91

Related Parent Nucleus of
[ 16382-15-3 ]

Indoles

Chemical Structure| 3770-50-1

A362351 [3770-50-1]

Ethyl indole-2-carboxylate

Similarity: 1.00

Chemical Structure| 16732-80-2

A126742 [16732-80-2]

Ethyl 4-methyl-1H-indole-2-carboxylate

Similarity: 0.97

Chemical Structure| 26304-51-8

A463569 [26304-51-8]

Ethyl 3-methyl-1H-indole-2-carboxylate

Similarity: 0.97

Chemical Structure| 1202-04-6

A187053 [1202-04-6]

Methyl 1H-indole-2-carboxylate

Similarity: 0.97

Chemical Structure| 107516-75-6

A261523 [107516-75-6]

Diethyl 1H-indole-2,6-dicarboxylate

Similarity: 0.91